1. Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland
2. Division of Tuberculosis Elimination, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia
3. Foundation for Innovative New Diagnostics, Geneva, Switzerland
4. Division of Pulmonary, Critical Care, and Sleep Medicine, University of San Diego, California
5. School of Population and Public Health, University of British Columbia, Canada
6. Clinical Prevention Services, British Columbia Centre for Disease Control, Vancouver, Canada
7. Nuffield Department of Medicine, University of Oxford, United Kingdom
8. IRCCS San Raffaele Scientific Institute, Milano, Italy
9. Columbus Technologies, Inc. Contractor to the National Institute of Allergy and Infectious Diseases, US National Institutes of Health, Bethesda, Maryland
10. Global TB Programme, World Health Organization, Geneva, Switzerland
11. Critical Path to Tuberculosis Drug Regimens, Critical Path Institute, Tucson, Arizona